Sectors/Healthtech/2012

Healthtech funding in 2012

European Healthtech startup funding raised during 2012.

In 2012, 70 European Healthtech companies closed 74 funding rounds and raised €480M in equity funding (excluding debt and grants). UK led by capital raised, and Amadeus Capital Partners was the most active investor. Data as of 6 Nov 2026.

Equity funding

€480M

excl. debt & grants

Funding rounds

Companies

Top country

Healthtech: last three years

change vs the year before

Year	Equity	Change	Rounds	Change	Debt
2010	€346M	+24.9%	45	+73.1%	—
2011	€528M	+52.8%	66	+46.7%	—
2012	€480M	-9.1%	74	+12.1%	—

Break down 2012 by period

Half-year

H1 H2

Quarters

Q1 Q2 Q4

Rank among sectors

10.3% of sector funding

Top-10 round share

67.4%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Jan	€21M	11
Feb	€22M	4
Mar	€8.6M	2
Apr	€3.7M	3
May	€119M	11
Jun	€14M	5
Jul	€54M	8
Sep	€115M	5
Oct	€16M	5
Nov	€60M	9
Dec	€58M	11

Top countries

by € raised

Data table

	Healthtech — top countries by capital, 2012
UK	€145M
Switzerland	€101M
Germany	€88M
Netherlands	€52M
Israel	€37M
France	€31M
Denmark	€11M
Sweden	€7.8M

Stage mix

by € raised

Data table

	Healthtech — stage mix, 2012
Series D+	€183M
Series C	€74M
Growth/Late	€66M
Other	€47M
Early VC	€43M
Series B	€28M
Series A	€26M
Seed	€14M
Grant	€10M

Exits & M&A

1 Buyout

1 exit.

Largest equity rounds

by disclosed amount, 2012

Company	Stage	Date	Amount
CureVac	Series D+	Sep 2012	€80M
Agendia	Series D+	May 2012	€49M
Oxford Nanopore Technologies	Growth/Late	May 2012	€39M
Biocartis	Series D+	Dec 2012	€35M
Endosense	Series C	Nov 2012	€31M
F2G	Growth/Late	Sep 2012	€27M
Cell Medica	Other	Jul 2012	€24M
GenKyoTex	Series C	Jul 2012	€21M
NeRRe Therapeutics	Series A	Dec 2012	€14M
EarlySense	Series D+	Nov 2012	€12M

View all 74 Healthtech deals in 2012 →

Top investors

most active in 2012, by deal count

Source: Tech.eu Funding Explorer · data as of 6 Nov 2026 · licence CC BY 4.0 · Methodology

← All-time Healthtech funding